|Tel: (708) 786-7737||Fax: (708) email@example.com||Contacts||Survey|
The 2014 Public Law Pricing Update Season FSS, NAC & PBM regulations & guidance are now available for review!
Stipulated in Public Law 102-585, Section 603 all brand name drugs must be made available for purchase under the 65 I B Schedule program at a not to exceed price as a condition for receiving payment from certain entities.
All affected suppliers must submit a proposal for a VA Schedule contract. We developed the Interim Agreement (IA) process to bridge the gap while negotiating a VA Schedule contract. The IA gives both the FSS Service and the supplier the time needed to move through the new offer review process, negotiations, and award of a new contract while allowing the supplier to immediately meet the requirements of P. L. 102-585.
This year we streamlined our interim agreement process for new suppliers and/or suppliers of new brand name drugs. As part of this process, suppliers are required to provide our office with
Upon receipt of this information we will provide your company with the relevant paperwork required to execute an interim agreement. Submit all interim agreement related inquires, comments, and documentation to the firstname.lastname@example.org
In addition to meeting the requirements of the 65 I B Schedule program, manufacturers of covered drugs must enter in to a Master Agreement (MA) and a Pharmaceutical Pricing Agreement (PPA) with the VA.
|Pharmacy Benefits Management Services||2013 PBM Annual Guidance (FINAL including CPI-U data) 2013 FCP Guidance for New Covered Drugs Non-FAMP New Product Request Templateemail@example.com|
|National Acquisition Center||2013 NAC Annual Guidance (Public Law Policy Group)||firstname.lastname@example.org|
|Federal Supply Schedule Service||2013 FSS Annual Guidance
2014 P.L. 102-585 Covered Drug Pricing Request for Modification Package
2014 P.L. 102-585 PPA Addendum A
P.L. 102-585 Frequently Asked Questions
|Public Law Core Team FSS Public Law Modifications|
|Index of Public Law Correspondence (1992 — Present) Public Law Correspondence Archive (1992 — Present)|
|FSS Public Law FAQs TRRx Sales & Non–FAMP FAQs|
Download the 2014 P.L. 102-585 Covered Drug Pricing Request for Modification Package. We will only process RFMs submitted using this year's forms.
Do not send requests directly to your permanent contract specialist. To ensure receipt of your firm’s request for modification, the Subject Line must have the following identifying information:
Modification requests submitted with missing or inaccurate information; or changes to the spreadsheet submitted after December 4, 2013 may have an adjusted effective date of January 15, 2014 or later. As a result, your firm may be subject to the penalties outlined in PL 102-585.
This is an abbreviated timeline. See the PBM, OGC & FSS Guidance for full instructions and due dates.
10/18…Receive Excel workbook with covered drug NDCs from PBM | 10/25…Report & describe modifications in existing methodology used to calculate non–FAMP to PBM, OGC, and OIG | 10/31…Report any disputes of the covered drug’s non–FAMP for 7/1/2012 — 9/30/2012 (3Q non–FAMP Old) | 11/15…Submit annual non–FAMP (10/1/2013 — 9/30/2013) and 3Q non–FAMP New (July 1, 2013 — September 30, 2013) to PBM | 11/18…PBM will begin calculating changes in non-FAMP pricing, additional discounts, and 2014 FCP. You will have two business days to dispute or resubmit calculations related to the 2014 FCPs to PBM, OGC, and OIG. | 12/04…The authorized official that signed your firm’s PPA Addendum for 2013 FCPs (or an authorized successor), must prepare and sign a new PPA addendum. Submit a properly prepared request for modification package to incorporate updated pricing into your FSS contract. To ensure receipt of your firm’s request for modification, the Subject Line must have the following identifying information: RFM-Contract Number-PL2014 (e.g. RFM-V797D-12345X-PL2014). Email your completed package to:email@example.com